Penn State scientists have discovered a novel drug target and have rescued functional deficits in human nerve cells derived from patients with Rett Syndrome, a severe form of autism-spectrum disorder. The research, led by Gong Chen, professor of biology and the Verne M. Willaman Chair in Life Sciences at Penn State, could lead to a new treatment for Rett Syndrome and other forms of autism-spectrum disorders. A paper describing the research was published on Jan. 4, 2016, in the online Early Edition of the journal Proceedings of the National Academy of Sciences.
“The most exciting part of this research is that it directly uses human neurons that originated from Rett Syndrome patients as a clinically-relevant disease model to investigate the underlying mechanism,” said Chen. “Therefore, the new drug target discovered in this study might have direct clinical implication in the treatment of Rett Syndrome and potentially for other autism-spectrum disorders as well.”
The researchers differentiated stem cells derived from the skin cells of patients with Rett Syndrome into nerve cells that could be studied in the laboratory. These nerve cells carry a mutation in the gene MECP2, and such gene mutations are believed to be the cause of most cases of Rett Syndrome. The researchers discovered that these nerve cells lacked an important molecule, KCC2, that is critical to normal nerve cell function and brain development.
“KCC2 controls the function of the neurotransmitter GABA at a critical time during early brain development,” Chen said. “Interestingly, when we put KCC2 back into Rett neurons, the GABA function returns to normal. We therefore think that increasing KCC2 function in individuals with Rett Syndrome may lead to a potential new treatment.”
The researchers also showed that treating diseased nerve cells with insulin-like growth factor 1 (IGF1) elevated the level of KCC2 and corrected the function of the GABA neurotransmitter. IGF1 is a molecule that has been shown to alleviate symptoms in a mouse model of Rett Syndrome and is the subject of an ongoing phase-2 clinical trial for the treatment of the disease in humans.
“The finding that IGF1 can rescue the impaired KCC2 level in Rett neurons is important not only because it provides an explanation for the action of IGF1,” said Xin Tang, a graduate student in Chen’s Lab and the first-listed author of the paper, “but also because it opens the possibility of finding more small molecules that can act on KCC2 to treat Rett syndrome and other autism spectrum disorders.”
The Latest on: Autism-spectrum disorder
via Google News
The Latest on: Autism-spectrum disorder
- Effects of age, sex and mindfulness on quality of life in men, women with autismon October 26, 2021 at 5:50 am
The practice of mindfulness was often touted throughout the pandemic as a useful tool for dealing with an unforeseen life stressor. As College of Health Solutions Assistant Professor Blair Braden ...
- Toms River's Autism Rate In Children Highest In NJ: Rutgers Studyon October 26, 2021 at 2:34 am
More than 70 in every 1,000 Toms River children — 7.3 percent, more than triple the national average — are on the spectrum, the study said.
- Slowness Therapy Shows Promise in Children With Autism Spectrum Disorderon October 22, 2021 at 8:30 am
Input slowing is based on the temporal theory of ASD that hypothesizes the audiovisual world changes too fast for children with ASD.
- Autism Speaks: Connecting a family with child on the ‘spectrum’ to information and resourceson October 19, 2021 at 2:11 pm
It is how many are on the autism spectrum. The developmental disorder is now often diagnosed by age two. Parents, or caregivers often notice avoidance of eye contact, a lack of interest in other ...
- Brightline Continues Rapid Expansion With New Autism Spectrum Disorder Services, Programs for LGBTQ and BIPOC Youthon October 18, 2021 at 10:28 am
On the heels of its recent nationwide expansion of behavioral health support and coaching programs for families, Brightline announced today it will be launching services for children with Autism ...
- Staten Islander creates film about mothers’ experiences raising children with autism spectrum disorderon October 16, 2021 at 7:47 pm
In her film, “Raising ASD,” Rachel Caccese shares the stories of. The docu-drama, which is based on interviews from mothers in New York City, will debut with a free screening at the Joan and Alan ...
- Understanding sex bias in autism spectrum disorderon October 14, 2021 at 2:44 pm
Autism spectrum disorders (ASDs) have long been noted to affect many more males than females, and accordingly, sex-specific factors have been hypothesized to increase males’ risk for, or protect ...
- Predictive Analytics Spots Autism Spectrum Disorders in Childrenon October 14, 2021 at 6:30 am
With predictive analytics, researchers can identify eventual diagnoses of autism spectrum disorder in young children.
- SOARS-B Trial Disappoints in Autismon October 13, 2021 at 2:02 pm
You can strike intranasal oxytocin off the list of potential treatments for autism spectrum disorder (ASD), results from the largest prospective trial to date indicated -- though not everyone agrees.
via Bing News